FDA Approves Antibiotic To Treat Intra-Abdominal Infections.

Reuters (8/27, Joseph, Mathias) reports the FDA approved Tetraphase Pharmaceuticals’ drug Xerava (eravacycline) to treat “complicated intra-abdominal infections, providing a new option to combat the growing threat from treatment-resistant bacteria.” The...